Pfizer Inc

NYSE: PFE
$24.80
-$0.30 (-1.2%)
Real Time Data Delayed 15 Min.

PFE Articles

The CEO of Chrysler said he took no pay in 2011 and that, based on financial results, the company is now worth $7.5 billion. (Reuters) The Treasury will sell $6 billion of AIG (NYSE: AIG) stock to...
Anheuser-Busch InBev NV may buy China’s Kingway Brewery Holdings’ assets. (Reuters) The Department of Justice is expected to widen its probe of mortgage-backed securities. (Reuters) AT&T...
Glencore and Xstrata are in merger talks. (Reuters) A federal mortgage deal with banks over mortgage fraud would give states enforcement power. (Reuters) Sony (NYSE: SNE) expects a $2.9 billion...
All three major indexes opened higher this morning, but the strength didn’t last as the Chicago PMI number failed to meet expectations and came in lower even than last month’s reading. The lower...
Pfizer, Inc. (NYSE: PFE) looks good on the surface on its earnings report for the fourth quarter, but the company’s guidance may be getting in the way a bit.  The drug giant turned in results of...
Tuesday is going to be full of major earnings reports, two of which are DJIA components.  These are not the only major earnings, but ten we will be watching closely are as follows:  Amazon.com Inc....
The tide of patent expirations that is washing over big pharmaceutical houses is cresting now and investors have begun looking forward to how these companies will deal with some sharp blows to their...
For several years it has been the case that Amgen Inc. (NASDAQ: AMGN) was considered a biotech though it had at least some of the same problems of Big Pharma players like Pfizer Inc. (NYSE: PFE)...
As each new year replaces the prior year, 24/7 Wall St. looks at the individual targets on all 30 Dow Jones Industrial Average price targets from Wall Street analysts to come up with a peak price for...